“Dose Reduction of Ibrutinib in Chronic Lymphocytic Leukemia: Long-Term Outcomes from a Real-World Single-Center Experience”. 2026. Mediterranean Journal of Hematology and Infectious Diseases 18 (1): e2026090. https://doi.org/10.4084/MJHID.2026.090.